{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:25:43Z","timestamp":1787689543493,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118059","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T15:15:38Z","timestamp":1755616538000},"page":"118059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Discovery of potent and selective PKMYT1 inhibitors for the treatment of CCNE1-amplified cancer"],"prefix":"10.1016","volume":"299","author":[{"given":"Haoyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhe","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhou","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5156-6125","authenticated-orcid":false,"given":"Dongmei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maosheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118059_bib1","doi-asserted-by":"crossref","unstructured":"C.T. Mueller PR, Kumagai A, Dunphy WG, Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15, Science 270 (1995) 86\u201390.","DOI":"10.1126\/science.270.5233.86"},{"key":"10.1016\/j.ejmech.2025.118059_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-020-00959-2","article-title":"A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target","volume":"13","author":"Ghelli Luserna di Ror\u00e0","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2025.118059_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.tcb.2021.05.001","article-title":"Cyclin E in normal physiology and disease states","volume":"31","author":"Chu","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118059_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tcb.2021.01.010","article-title":"New insights into CDK regulators: novel opportunities for cancer therapy","volume":"31","author":"Bury","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118059_bib5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3390\/molecules22122045","article-title":"Regulation of G2\/M transition by inhibition of WEE1 and PKMYT1 kinases","volume":"22","author":"Schmidt","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118059_bib6","first-page":"74","volume":"vol. 23","author":"Matthews","year":"2022"},{"key":"10.1016\/j.ejmech.2025.118059_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: a critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118059_bib8","doi-asserted-by":"crossref","unstructured":"D.J. Do K, Kummar S, Wee1 kinase as a target for cancer therapy, Cell Cycle. 12 (2013) 3159-3164.","DOI":"10.4161\/cc.26062"},{"key":"10.1016\/j.ejmech.2025.118059_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2897","article-title":"Causes and consequences of replication stress","volume":"16","author":"Zeman","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118059_bib10","doi-asserted-by":"crossref","first-page":"17997","DOI":"10.1021\/acs.jmedchem.4c01619","article-title":"Targeting protein kinase, membrane-associated tyrosine\/threonine 1 (PKMYT1) for precision cancer therapy: from discovery to clinical trial","volume":"67","author":"Yang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-022-04638-9","article-title":"CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition","volume":"604","author":"Gallo","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.118059_bib12","doi-asserted-by":"crossref","first-page":"10251","DOI":"10.1021\/acs.jmedchem.2c00552","article-title":"Discovery of an orally bioavailable and selective PKMYT1 inhibitor, RP-6306","volume":"65","author":"Szychowski","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib13","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1158\/1538-7445.AM2025-1733","article-title":"Abstract 1733: XL495 is a potent, selective, and orally bioavailable inhibitor of PKMYT1","volume":"85","author":"Gwinn","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118059_bib14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1158\/1538-7445.AM2025-1743","article-title":"Abstract 1743: QLS1209, A highly potent and selective PKMYT1 inhibitor demonstrates activity in tumors with CCNE1Amp and\/or FBXW7LoF mutations","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118059_bib15","volume":"85","author":"Shi","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118059_bib16","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/1538-7445.AM2025-3025","article-title":"Abstract 3025: optimization of therapeutic index of SGR-3515, a first-in-class Wee1\/Myt1 inhibitor through intermittent dosing for monotherapy and combination with chemotherapy in xenograft tumor models","volume":"85","author":"Sun","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118059_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006367032156","article-title":"Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy","volume":"17","author":"Dimitroff","year":"1999","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.ejmech.2025.118059_bib18","doi-asserted-by":"crossref","first-page":"8497","DOI":"10.1021\/acs.jmedchem.5c00114","article-title":"Discovery of naphthyridinone derivatives as selective and potent PKMYT1 inhibitors with antitumor efficacy","volume":"68","author":"Chen","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib19","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1021\/acs.jmedchem.4c01458","article-title":"Structure-based drug design of 2-Amino-[1,1'-biphenyl]-3-carboxamide derivatives as selective PKMYT1 inhibitors for the treatment of CCNE1-Amplified breast cancer","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117025","article-title":"Discovery of pyrrolopyrimidinone derivatives as potent PKMYT1 inhibitors for the treatment of cancer","volume":"281","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib21","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/acs.jmedchem.4c00817","article-title":"Discovery of tetrahydropyrazolopyrazine derivatives as potent and selective MYT1 inhibitors for the treatment of cancer","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib22","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1039\/D4MD00389F","article-title":"Structure-based virtual screening discovers novel PKMYT1 inhibitors","volume":"15","author":"Zhang","year":"2024","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib23","unstructured":"CCNE1 copy number (2024Q2) can be accessed via DepMap(https:\/\/depmap.org\/portal\/). Any copy number exceeding 1.58 is considered as \"CCNE1-amplification\u201d, see Ref 11."},{"key":"10.1016\/j.ejmech.2025.118059_bib24","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1039\/D2NJ05691G","article-title":"Design, synthesis and biological evaluation of highly potent and selective CYP1B1 inhibitors","volume":"47","author":"Zhang","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib25","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118059_bib26","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2025.118059_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expet Opin. Drug Discov."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:13:18Z","timestamp":1762265598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S0223523425008244"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118059","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of potent and selective PKMYT1 inhibitors for the treatment of CCNE1-amplified cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118059"}}